Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Zai Lab On Portfolio Strategy In Post Coronavirus China
Adapting To Changing Oncology Market
Apr 21 2020
•
By
Brian Yang
SHANGHAI'S ZAI LAB EXPANDS PORTFOLIO TO COMPETE IN POST-CORONAVIRUS CHINA • Source: Shutterstock
More from China
More from Focus On Asia